000513 · Livzon Pharmaceutical Group, Inc. Class A
29.61
CNYUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Yuan24.91B
PE
15.20
EV/EBITDA
8
DIV Yield
4.4%
Payout Ratio
67%
MQV Rating
3Neutral
As at 08/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- HALO All
- HALO Price Momentum
- Near Resistance
- Recent Price downgrade
- Volume Spike
Key Fundamentals
EPS 3 yr Growth
10.90%
EBITDA Margin
26.70%
Operating Cashflow
¥3,179m
Free Cash Flow Return
21.20%
ROIC
13.50%
Interest Coverage
51.50
Quick Ratio
2.00
Performance
52 weeks range
Low 25.74 - 39.28
Trade Value (12mth)
US$7,764,833.00
1 week
22.99%
1 month
23.22%
YTD
-6.4%
1 year
-17.11%
All time high
62.20
Additional Data
Shares Outstanding (Fully Diluted)
888m
HALO Sector
Healthcare
Next Company Report Date
31-Mar-27
Next Ex Dividend Date
14-Oct-26
Next Dividend Pay Date
14-Oct-26
Reporting Currency
CNY
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Neutral
Garp
Weak
Mqv Small
Neutral
Momentum
Price
Very Strong
Earnings
Neutral
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Strong
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
21 August 25Flash | |
24 April 25Flash | |
27 March 25Flash | |
24 October 24Flash |
Key Stakeholders
| Name | Title |
| Joincare Pharmaceutical Group Industry Co., Ltd. | Public Company |
| Livzon Pharmaceutical Group, Inc. | Public Company |
| Xiao Qiang Peng | Individual |
| De Sheng Tao | Individual |
| Guo Xiang Xu | Individual |
